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ABSTRACT 
Background of Study Design 
Physician-assisted suicide (PAS) and euthanasia have repeatedly emerged as 
issues of debate regarding end-of-life treatment for patients with intractable pain, 
terminal illnesses and /or other debilitating diseases. Amyotrophic lateral sclerosis 
(ALS) is a non-curable, debilitating neurological disease that causes progressive 
paralysis and eventual respiratory failure. Patients with ALS are in unique 
positions to contemplate end-of-life care issues due to the predictability of the 
course of the disease. While some have expressed an interest in pursuing PAS 
and/or euthanasia in order to control the circumstances of their deaths, it is not 
known how many have done so. In addition, little information is known about 
how much physicians of ALS patients understand their patients' interest in these 
options. 
Methods 
Physicians of ALS patients will be identified in neurology clinics throughout 
North Carolina. Mailed questionnaires will be sent to physicians over a 4-month 
period. They will be asked about their understanding of their ALS patients' 
wishes concerning end-of-life care including PAS and euthanasia. ALS patients, 
identified through these physicians, will be asked to complete questionnaires 
pertaining to their wishes regarding end-of life care. These questionnaires will be 
completed through semi-structured interviews. 
Results 
To be completed 
Conclusion 
It is predicted that physicians of ALS patients will underestimate their patients' 
interest in PAS and euthanasia. 
Research Question: Do physicians of Amyotrophic Lateral Sclerosis (ALS) 
patients know what their patients' wishes are concerning end-of-life care, 
particularly physician-assisted suicide (PAS) and euthanasia? 
BACKGROUND 
Natural History of ALS 
Amyotrophic Lateral Sclerosis (ALS) is a debilitating and fatal neurological 
disease that affects approximately 1-2 per 100,000 individuals in the United 
States. It tends to affect males more than females at a rate of 2:1 and onset is 
usually after age 50. While the cause is unknown, approximately 5% of cases 
are familial (autosomal dominant), the remainder being sporadic. Many of the 
familial cases have been linked to the super-oxide dismutase gene on 
chromosome 21. 
The disease is characterized by degeneration of upper and lower motor 
neurons. Initial manifestations in most cases include weakness of the hand 
muscles followed by progressive weakness of the remainder of the limbs, 
dysarrthria (slurred speech) and dysphagia (difficulty swallowing). Cramping 
and fasciculations (twitches) of the muscles, particularly the forearm, upper 
arm, shoulder girdle and tongue appear along with muscle atrophy. Head 
droop, a distinguishing feature of ALS occurs due to weakness of the thoracic 
and cervical muscles. Initially, loss of reflexes may occur (due to lower 
motor neuron disease), but is eventually replaced by hyperreflexia and 
spasticity as upper motor neurons become more affected. 
As the disease advances, patients lose weight rapidly due to disuse of muscles 
and difficulty swallowing and thus inadequate caloric intake. All patients 
eventually become wheel chair bound. Activities of daily living become 
difficult and patients must rely on assistance from others. Pseudobulbar 
palsy, a term used to define inappropriate emotional outbursts due to disease 
of upper motor neurons, is common. Drooling becomes uncontrollable and 
aspiration of liquids, food and saliva pose a frequent threat. Paradoxically, 
bowel and bladder function are preserved. Sensory function and mental 
capacity are also preserved. Eventually, respiratory failure ensues and is the 
predominant cause of death unless ventilatory support is provided. 
Time until death is, on average, three years after symptoms first appear. 
There is no cure and treatment consists of supportive care. Depression, 
hopelessness, anxiety, feelings of isolation and frequent sensations of 
choking and difficulty breathing typify the terminal phase.1 Quality of life is 
greatly reduced. 
?. 
End-of-Life Care for ALS Patients 
Due to the predictability of the course of the disease, patients with ALS and 
their families find themselves in a unique position to contemplate issues 
concerning end-of-life care. Since the patients' intellects remain intact, they 
have the opportunity to make informed decisions regarding their care. Issues 
such as whether or not to have ventilatory support once respiration becomes 
impaired, to insert feeding tubes to maintain adequate nutrition and to receive 
palliative care for pain are all relevant. Not only are issues concerning the 
maintenance of life frequently addressed, but also issues concerning the 
termination of life. Specifically, ALS patients may find themselves exploring 
various methods of dying. 
Controversies Surrounding Physician-Assisted Suicide and Euthanasia 
When surveyed, many ALS patients have expressed interest in assisted 
suicide and/or euthanasia as possible options.2 Physician-assisted suicide 
(PAS) is defined as assistance to a patient's termination of life by a 
physician, usually by prescribing lethal doses of narcotics that the patient 
then self-administers. Euthanasia refers to the active administration of lethal 
medications directly by the physician in cases where the patient is unable to 
do so herself due to paralysis or inability to swallow. Today, medical 
advances are allowing prolongation of lives that would normally have 
succumbed to many diseases. Because artificially induced life prolongation is 
increasingly more available through parenteral nutrition, ventilatory support 
and cardiac support, questions pertaining to withdrawal of artificial support 
become relevant. 
To many, PAS and euthanasia are natural extensions to the discussions of 
withdrawal of care. Indeed, ethicists argue that PAS/euthanasia are, in 
essence, the same as withdrawal of care since the end goal of all three 
methods is the same, namely to facilitate death, regardless of the means.' 
They further argue that to allow withdrawal of care, but to deny PAS and 
euthanasia to those who also wish to facilitate their deaths is a form of 
discrimination. In other words, those patients whose lives are not dependent 
on artificial support are the "unlucky" ones who are denied the option of 
terminating their lives painlessly even though they may suffer equally or 
more than those living with life support. Even more unfortunate, according to 
this argument, are those incapable of self-administering lethal doses of pain-
killers due to paralysis, for example, and thus must rely on euthanasia to end 
their suffering in a desirable manner, a practice that is considered even more 
controversial by many than PAS. 
Opponents of PAS and euthanasia fear that if these practices are legalized, 
then the potential for abuse of these practices becomes much higher. One 
such "slippery slope" argument is based on the concern that PAS and 
euthanasia will be used too readily before other options have been 
exhausted. 4 For example, depression in patients might not be recognized or 
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adequately treated before termination oflife is considered. Patients suffering 
from unbearable pain might opt for ending their lives without having had 
appropriate pain management. Alternatively, there is a fear of discrimination 
against the poor or members of minority groups. Opponents ask if these 
groups will be coerced into PAS or euthanasia as alternatives to more 
expensive treatments. 5 Thus, they ask, will end-of-life decisions be tainted 
by subtle or not so subtle economic coercion? Not only could the medical 
system be tainted, but also so could the patients' families and the patients 
themselves. Patients might be influenced by family members or by their own 
concerns of being a "burden" to others and as a result, too readily opt for 
ending their lives. Opponents fear that there are too many "slippery slopes" 
that could arise if PAS and euthanasia are allowed. They argue that we 
cannot adequately ensure that these practices would be used appropriately 
and without abuse, and thus should not be legalized. 
In the United States today, while withdrawal of life-support at the patient's 
request is legal and recognized as a Constitutional right nationwide (a liberty 
to autonomy protected by the Fourteenth Amendment), PAS is only legal in 
the state of Oregon and only under certain conditions. Euthanasia is illegal 
throughout the US. This is not the case in many parts of the world, however. 
In the Netherlands, for example, both PAS and euthanasia are accepted 
practices for alleviating suffering in the terminally ill. 
Although PAS and euthanasia are currently illegal in most of the US, both the 
legalities and ethics of these practices continue to be hotly debated. Ethicists, 
legal and medical experts, patient advocacy groups and politicians are 
bringing these issues to the forefront of public discourse. The ethical 
dilemmas concerning PAS and euthanasia will not magically disappear until 
we have adequately addressed all facets of these dilemmas. As we attempt to 
evaluate and clarify these issues, it becomes vital that any further decisions 
made be based on appropriate and comprehensive information. It is important 
that we understand all viewpoints on these topics. 
Understanding the Patient's Wishes 
Perhaps most importantly, it is vital that we understand the wishes of the 
patients themselves. Cancer patients, those with chronic pain and/or 
debilitating disease and the terminally ill are potentially the most affected by 
any further decisions that either allow or forbid these practices. We need to 
understand what they want. Do they wish to have the options of PAS and 
euthanasia? If so, are we failing as medical practitioners by not providing a 
much-desired service? Are we being remiss in our obligations to 
appropriately treat suffering? 
ALS patients have a unique role in this debate due to a combination of 
several factors. Their disease is presently non-curable and terminal, their 
quality of lives are often markedly reduced and their mental capacities remain 
preserved, allowing them to continue to make informed decisions regarding 
their health care through the final phases of their disease. ALS patients have 
expressed many common concerns and fears about the dying process itself.6 
Fears about choking to death or dying painfully through respiratory failure 
are frequently cited. In addition, since most patients are paralyzed by the 
terminal phase, the issue of euthanasia becomes particularly relevant since 
they are unable to voluntarily terminate their lives on their own. Thus, their 
views on these issues and our understanding of their views are central to this 
debate. 
This proposed research study will further our understanding of the views of I 
ALS patients concerning these issues. Furthermore, it will explore whether or 
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not the physicians of ALS patients understand their patients views. The 
hypothesis of the proposed study is that physicians of ALS patients are 
underestimating their patients' desires for euthanasia or PAS. The ultimate 
goal of this study is to determine if the US medical community (with the 
exception of Oregon) is appropriately addressing end-of-life concerns and if 
we are failing to provide services that are commonly desired by ALS patients. 
The following section summarizes prior research that has attempted to 
understand the views of ALS patients regarding these issues. The strengths 
and weaknesses of these studies are explored. In addition, gaps in the 
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literature where more research is needed is discussed as well as further 
rational for this proposed study. 
REVIEW OF MEDICAL LITERATURE 
A Medline electronic search was conducted of studies published between 
1970 and February 2004 using the search terms "amyotrophic lateral sclerosis 
AND assisted suicide", "amyotrophic lateral sclerosis AND euthanasia", 
"ALS AND euthanasia" and "ALS AND assisted suicide". Limits included 
English language and human subjects. From the 130 total articles displayed, 
only those that were either original research studies or reviews of studies 
were chosen. Additional searches included the key words "amyotrophic 
lateral sclerosis AND end of life" or "ALS AND end of life". Related articles 
on Medline were reviewed for the following two articles from the earlier 
searches: 
Silverstein MD, Stocking CB, Ante! JP, Beckwith J, Roos RP, Siegler M. 
Amyotrophic lateral sclerosis and life sustaining therapy: patient's desires for 
information, participation in decision making, and life-sustaining therapy. 
Mayo C!in Proc. 1991;66(9): 906-13. 
Schneiderman LJ, Kaplan RM, Rosenberg E, Teetzel H. Do physicians' own 
preferences for life-sustaining treatment influence their perceptions of 
L 
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patients' preferences? A second look. Carnb Q Healthc Ethics. 1997; 6(2): 
131-7. 
All articles identified by the search were screened by the author. Only articles 
which were either available on-line or were available in the UNC Health 
Sciences Library were selected. A total of nine articles were assessed as 
relevant and were included in this review. 
STUDIES OF GENERAL EXPERIENCE WITH PAS/EUTHANASIA 
Mter PAS became legalized in Oregon, Ganzini et al, surveyed 2649 
physicians eligible to prescribe lethal medications in Oregon.7 Physicians 
were asked for information on all terminally ill patients who had requested 
lethal medication for assisted-suicide. The physicians covered a wide range 
of disciplines, including neurology, internal medicine, family practice, and 
gynecology. 
Between the years 1997 and 1999, 165 patients had requested assistance with 
suicide. The majority of these patients were male (52%), Caucasian (97% ), 
had completed high school (95%) and had medical insurance (98% ). The 
average age was 65. Most patients (93%) were deemed mentally competent 
by their physicians and most suffered from cancer (67%). According to the 
physicians, the most common reasons for requesting PAS were loss of 
independence (57%), poor quality of life (55%), pain (43%) and desire to 
control circumstances of dying (53%). Reasons such as perceived financial 
burden on others or lack of social support were given for only 11% and 6% 
respectively. 
In total, 18% of patients actually received prescriptions for PAS and10% 
ultimately died via PAS. There were many reasons for not honoring the 
patients' requests including the presence of depression. 
Sullivan eta!, studied PAS in the second year after it became legal in 
Oregon. 8 Through interviews with physicians and family members of 
decedents of PAS and through death certificates, they found 33 patients who 
' 
had requested prescriptions for lethal medications. Out of these 33, 26 
actually died via PAS. The median age of these patients was 71. Cancer was 
the most frequent diagnosis (63%) followed by ALS (15%). As with the 
previous study, most patients had at least high school education (92% ), all 
had some form of insurance and most were male and Caucasian (96% and 
59% respectively). According to the physicians and family members 
interviewed, the predominant reasons for wanting PAS were concerns of loss 
of autonomy, inability to participate in joyful activities, physical suffering 
and loss of control of bodily activities. One patient was concerned about 
medical costs and eight were concerned about being burdens on others. 
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Limitations to both of these studies include using surrogates rather than 
interviewing the patients directly. Since these interviews were conducted 
after the patients committed PAS, there was also potential for recall bias. 
However, since PAS is mandated as reportable in Oregon, all cases of PAS 
could be analyzed. 
The results of both studies suggest that even though legal in Oregon, PAS is 
requested by a small minority of patients. Of those who do request it, the 
majority are terminally-ill Caucasians with at least high school education and 
with some form of medical insurance. Among their top reasons for requesting 
PAS are loss of independence and desire for control over their lives. Perhaps I 
most importantly, lack of financial or social support was rarely cited as ' 
reasons for their requests. 
STUDIES ASSESSING ALS PATIENTS DIRECTLY 
Rabkin et a!, surveyed a total of 56 ALS patients on their willingness to 
consider assisted suicide and on other quality of life issues. 9 The patients in 
this study were consecutively selected from ALS patients being seen at the 
Lou Gehrig Muscular Dystrophy Association (MDA)/ALS Center of the New 
York Presbyterian Hospital. Semi-structured interviews were conducted. The 
patients also completed the Beck Depression Inventory and other quality-of-
life surveys. Among the ALS patients, 34% stated that they would consider, 
under certain circumstances, asking for a prescription of medicine for the 
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purpose of ending their lives. Fifty percent said they would not and 8% were 
undecided. The authors found that those patients who were willing to 
consider assisted suicide did not differ significantly in degree of suffering, 
distress or depression from those who would not consider such an action. 
Euthanasia was not addressed in this study. 
There are several limitations to this study. First, the patients were selected 
from a tertiary and specialty clinic and thus may have had more severe 
symptoms of disease or were more knowledgeable of their disease. This 
selection bias may have led to an overestimate of the frequency of 
willingness to consider PAS. Second, the majority of the patients (80%) were 
Caucasian and thus not necessarily representative of all ALS patients. Third, 
the small number of subjects limits the strength of this study. Finally, no 
information was given regarding characteristics of patients who refused to 
participate in the study. This information is necessary to evaluate for 
potential selection bias. 
There were several strengths of this study that includes the use of validated 
instruments for surveys, such as the Beck Depression Inventory (BDI). The 
authors also included spirometry measures of FVC to evaluate degree of 
impairment in addition to using levels of function questionnaires. Also the 
patients in this study, other than being predominately white, represented a 
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wide range of characteristics with regards to education level, religious 
affiliation, and sex and employment status. 
Ganziui et al, surveyed both ALS patients and their caregivers in Washington 
and Oregon. 10 Subjects were selected from patients in the ALS clinic at 
Oregon Health Sciences University in Portland, Oregon, or had either 
participated in or expressed prior interest in participating in research studies. 
In total, 100 patients and 91 family caregivers agreed to participate. Fifty-six 
percent of patients surveyed were willing to consider assisted-suicide (via 
prescriptions to end their lives). These patients were more likely to be men, 
were less religious, more educated and had lower quality of life scores than 
those who would not consider assisted death. In addition, even though there 
were no significant differences in depression scores between these two 
groups, the former group did collectively have higher scores of hopelessness. 
Euthanasia was not addressed. 
Among the caregivers, most of whom were spouses, 62% would support the 
patient's decisions to end their lives via PAS. There was agreement on this 
decision between caregivers and patients 73% of the time. The caregivers 
who supported PAS were less religious than those who did not. Overall, the 
authors found no significant differences between patients with an interest in 
PAS and those without in education level, extent of social support, degree of 
disability or presence or absence of suffering, depression or perceptions of 
being a burden to the caregivers. 
Strengths of this study include direct responses by ALS patients rather than 
by surrogates. Selection criteria were adequately described. Also, 
standardized instruments for evaluating depression, social support and 
hopelessness were used. Limitations of this study include a selection bias 
since all patients were selected from a tertiary clinic or had shown or 
expressed interest in research participation. It is possible that these patients, 
in general, are more educated about their disease and may be more willing to 
discuss or consider assisted death. No information was provided on the 
characteristics of subjects who refused to participate which may influence the 
outcome. The majority of patients were highly educated Caucasian males, 
which limits the generalizability of these results. Finally, the authors used 
education level as a marker for socioeconomic status, which may not be 
accurate. 
These studies support many of the results from the studies in the previous 
section. Again, it appears that the majority of patients who would consider 
PAS are Caucasian males with less religious affiliation and are better 
educated, on average, than those patients who would not consider PAS. Also, 
depression and perception of being burdens to others were not significantly 
14 
associated with interest in PAS. Hopelessness, however, was positively 
correlated with interest in PAS. 
STUDIES ASSESING VIEWS AND OF ALS PATIENTS VIA 
SURROGATES 
In the Netherlands, PAS and euthanasia, while not legal, are not punishable. 
Physicians of 279 patients with ALS who had died between 1994 and 1998 
participated in a study by completing questionnaires about the end of life 
decisions of their patients. 11 Two hundred and three physicians participated; 
the remainder who refused (26%) predominately cited lack of time as their 
reason for refusal. The patients were identified through referrals to two 
national ALS centers. 
According to the responding physicians, 17% of the patients died by 
euthanasia and 3 %by PAS. The patients who died by euthanasia differed 
from those who died by PAS in the level of functioning of their arms. 
Patients who had a physician-assisted death (either by suicide or euthanasia) 
did not differ significantly from those who died by other means in education 
level, income, and disease-related or care-related characteristics. There were 
also no significant differences in the severity of pain, despair or fear. 
Interestingly, physician-assisted death was negatively associated with 
feelings of anxiety before death. Reasons for the decreased anxiety in these 
patients were not pursued. 
l'i 
There are obvious limitations to this study. Perhaps the most significant is the 
fact that physicians, rather than the patients themselves, completed the surveys. 
There is great potential for erroneous responses, particularly to those questions 
evaluating patients' emotions. Thus, information bias, as well as recall bias, 
could be a factor. A second limitation, as the authors discuss, is the potential 
for selection bias since the patients were identified through university clinics. 
Also, this study may only pertain to Dutch patients for whom income status 
may not play a large role in their decisions on dying since almost all Dutch are 
insured. In addition, greater public acceptance of physician-assisted death in 
the Netherlands may mean that these results cannot be generalized to patients 
in the US. 
Ganzini and colleagues conducted a second study in this area.12 In this study, 
50 family caregivers of decedent ALS patients in Oregon were surveyed. 
Selection criteria included prior enrollment of patients in either the Portland 
Veterans Affairs Medical Clinic or the Oregon Health Sciences University 
muscular clinic or participation in the previously discussed study.10 
Caregivers were asked a number of questions pertaining to the last month of 
the patients' lives. 
According to the caregivers, 32% of patients had discussed wanting PAS in 
the last month. Only one patient, however, actually died via PAS. Patients 
who had expressed interest in PAS were more likely to have insomnia, to feel 
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as a burden on their families, and to have more discomfort or pain than those 
who did not explicitly express a desire for PAS. Of the caregivers who had 
participated in the previous study, almost half of the patients who had 
expressed an interest in PAS early on maintained that desire, according to the 
caregivers. 
This study was a follow-up of the prior study by Ganzini et al. 10 Thus, the 
authors were able to ascertain how many of the patients who had previously 
expressed an interest in PAS actually died by that method. Another strength 
is the use of validated survey instruments. 
However, since this study relied on caregiver reporting, the accuracy of their 
answers is unknown. There is also the potential of recall bias. Selection bias 
may play a role due to the same reasons discussed in the previous study. 
There is no information on the characteristics of those who did not participate 
in the study and the small sample size limits the strength of this study. 
Finally, a lack of overt expression of desire for PAS does not imply that the 
patients did not privately wish for this. There may be many reasons for not 
discussing this desire with caregivers, including fear of disagreement, of 
alienation or of distressing their caregivers. 
Unlike the previous studies discussed thus far, the Netherlands study revealed 
no significant difference in education level between those patients who died 
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via PAS and those who did not. 11 In addition, the study by Ganzini and 
colleagues does suggest that perceptions of being burdens on caregivers is 
associated with desire for PAS.12 Both of these results contradict the results 
of the prior studies in regards to these factors. It is unclear why this is so, 
however, the discrepancies could be due to differences in culture (between 
the US and the Netherlands) and in using surrogates to obtain answers. 
STUDIES ASSESING PHYSICIANS' KNOWLEDGE OF PATIENTS' 
WISHES 
In this literature search, no studies directly comparing ALS patients' 
preferences on end-of-life care and their physicians' understanding of these 
preferences were found. Studies involving other patients are discussed 
below. 
Schneiderman et al, identified 36 patients who had advanced directives with 
life-threatening illnesses from specialty clinics in San Diego.13 Physicians of 
22 of these patients participated in the study while 8 refused due to lack of 
knowledge of their patients. Thus in all, 22 patients and their corresponding 
physicians (16 in all) were interviewed about end-of-life decisions. Patients 
were asked to give their preferences on end-of-life care for 4 different 
scenarios and their physicians were asked to predict what their patients' 
responses would be. Overall, there was very poor correlation between 
patients' wishes and their physicians' predictions. For example, while 93% of 
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the patients wished for CPR in cases of cardiac arrest, only 61% of their 
physicians accurately predicted this. In all, physicians' predictions more 
closely matched what they would prefer for their own care rather than what 
their patients truly desired. 
Limitations to this study include the very small sample size. Also, since all 
patients had advanced directives, it is possible that discussions between 
physicians and their patients may have led to greater understanding of 
patients' wishes than would occur with the general patient population. 
Despite this, a significant portion of physicians initially approached (50%) 
refused to participate in this study; citing insufficient knowledge of their 
patients as their reason for refusal. Thus, there is a clear bias for patient and 
physician selection, which may have resulted in data skewed toward positive 
correlation between patient and physician responses. This study appears to 
support a lack of physician understanding of patients' wishes. 
A second study surveyed 28 physicians of 35 patients with advanced AIDS or 
cancer.14 Thus there were a total of 35 patient-physician pairs. Again, 
physicians were asked to predict their patients' choices on various end-of-life 
scenarios. In all, there was 63% perfect agreement between patient wishes 
and their physicians' predictions. In general, the correlation was highest in 
situations involving very invasive treatments such as CPR and mechanical 
ventilation and lowest in situations involving less invasive treatments such as 
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use of antibiotics or pain medication. As with the previous study, physicians' 
predictions more closely matched their preferences for their own care rather 
than that for their patients. 
Limitations include a small sample size and selection of patients from a 
tertiary clinic (and thus limited generalizability). Also, no detailed 
information regarding the patients' and physicians' demographics was 
included. Thus vital information such as years of practice of physicians and 
race, sex and socioeconomic status of patients were not provided, all of 
which could influence the results. 
Coppola et al, conducted a similar study as above involving 41 physicians (24 
primary care and 17 hospital-based) and 82 elderly outpatients.15 As with the 
previous studies, their goal was to assess the accuracy of physicians' 
predictions of patients' preferences for treatments in several different life-
threatening scenarios with and without advance directives. These physicians 
were allowed to review advance directives on approximately half of the 
patients before completing the questionnaire. Consistent with other similar 
studies, physicians did not, as a group, accurately predict their patients' 
preferences. Overall, predictions were accurate 66% of the time for primary 
care physicians and 64% of the time for hospital-based physicians. The 
accuracy of physicians' predictions with their patients' advance directives 
improved by 20% overall to a total of70%. 
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Limitations in this study include a small sample size and limited demographic 
range of both physicians and patients. For example. physicians and patients 
were predominantly Caucasian and either Protestant or Catholic. Subjects were 
also selected from a limited area in Ohio. A selection bias may have been 
present if those who chose to participate in this study were already interested in 
the subjects of end-of-life care and advance directives. Thus accuracy of 
predictions may be higher in this study than would be with the general patient 
and physician population. Unfortunately, the authors did not provide 
information on the number of potential subjects who refused to participate or 
their reasons for refusals. 
From these above studies, it appears that physicians as a whole have minimal 
understanding of their patients' preferences regarding end-of-life care and 
treatments. However, the number of these studies is small. Also, none of 
these studies specifically assessed ALS patients or views on euthanasia 
and/or PAS. This is an area in obvious need of investigation. 
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METHODS 
Study Population 
The data gathered for this proposed study will be obtained primarily through 
cross-sectional surveys. Both ALS patients and physicians of ALS patients 
will be surveyed. To meet the criteria for eligibility in the study, physicians 
must be licensed neurologists practicing in the state of NC and actively 
caring for at least one ALS patient. Criteria for subject eligibility for ALS 
patients will include the following: 
• Patients must be adults with either documented, confirmed or 
suspected diagnosis of ALS 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Must be currently receiving care from a neurologist in North Carolina 
Must have had documented ALS for at least 1 year 
Must be aware of their diagnosis 
Must be mentally competent 
Must have no other major untreated mental or physical co-morbid 
disorders 
Must be documented citizens of the US 
Must be able to give either verbal or written consent 
Must live in North Carolina 
Must speak English 
Must have a home telephone 
Neurologists throughout the state will be contacted via phone for verbal 
consent to participate in surveys. ALS patients will be identified through the 
participating neurologists. 
Initially, the patient survey will be piloted by 3-5 ALS patients who meet the 
above criteria and who will be identified in the waiting rooms of the Duke 
and UNC neurology clinics. Permission will be obtained for participation in 
30- 45-minute semi-structured interviews. Those who consent will be 
presented with a sample survey. Their answers to the survey questions will be 
sought. In addition, they will be asked for any recommendations regarding 
the format and content of the survey. The goal would be to include questions 
that the patients themselves deem relevant and omit those that they don't. 
After these initial interviews, the survey will be further refined and finalized. 
The patients who participate in this initial series of interviews will not be 
eligible for participation in the final survey. 
Mter the surveys are finalized, eligible candidates will be phoned and asked 
to consent to participate in the study and appointments will be made for 
survey completion through personal interviews. These interviews will be 
conducted either at the patients' homes or in health clinics, at their discretion. 
Thus 2 different questionnaires will be developed, one for the physicians and 
the other for patients, both based on results of the interviews with patients. 
Since this is a pilot study, the goal will be to have surveys completed by at 
least 15 physicians and up to 15 patients. As previously stated, patients will 
be surveyed in person for mainly two reasons; 1) to allow participation of 
patients with physical limitations that may prevent their completing the 
questionnaire and 2) to eliminate any confusion or misconceptions regarding 
the questions. Physician subjects, however, will be surveyed through mailed 
questionnaires, the rationale being that they have more limited time for 
participation and thus written questionnaires sent through the mail will lead 
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to greater participation. In addition, physical limitations of the physicians will 
be of minimal concern. 
Prior to initiation of this study, approval will be obtained by the Human 
Subjects Committee of the University of North Carolina, Chapel Hill School 
of Public Health. 
SURVEYS 
The initial draft survey presented for evaluation by ALS subjects will contain 
various questions pertaining to end-of-life issues. Patients will be asked for 
their opinions on various aspects of end-of-life care including the options of 
physician-assisted suicide and euthanasia. They will be adapted from other 
·surveys asking similar questions. The goal is to develop a survey that closely 
matches those of other studies so that comparisons of results can be more 
easily made between this and other studies. L 
General questions asking patient and physician demographics, such as race, 
religion and income will be included to evaluate for any trends based on these 
characteristics. Race, marital status and education level have been shown to 
differ between those who would consider PAS and those who would not in 
several studies . .,10 However, other studies have revealed no significant 
differences.7,11This study will measure these same characteristics in order to 
assess if these characteristics do influence patient decisions. In addition, 
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similar characteristics of physician subjects will be assessed to evaluate for 
influencing factors on physicians' assumptions of patient preferences. 
Religiosity is negatively associated with interest in PAS/euthanasia in two of 
the studies reviewed. 10· II The author of this study will measure religiosity by 
a question similar to that used in one reviewed study .10 
Since studies assessing depression, pain and discomfort as possible indicators 
of interest in PAS or euthanasia have given mixed results, the author of this 
study will further explore these issues by asking questions based on those 
used in these studies.10· II.Iz Questions concerning present and future 
treatments have been developed for this study in order to assess for 
consistency in patients' treatment desires. The purpose of these questions is 
to gauge the overall attitudes of patients to various end-of-life issues. Their 
responses will be compared to those by the physicians in order to assess the 
degree of agreement between what the patients' attitudes are to these 
treatments and what the physicians believe their patients' attitudes are. The 
influence of advanced directives on physician understanding of their patients' 
preferences has only been evaluated by one study and thus will be further 
evaluated in this study using similar questions. Is In addition, questions 
concerning physician-patient interaction have been developed for this study 
in order to assess influencing factors on physician understanding of patients. 
All questions will be closed-ended and answers will either be yes/no or in a 
Likert scale format. The Likert scale is traditionally a 5-point ordinal scale in 
which subjects are asked to express degree of agreement or disagreement on 
a 5-point scale. Each degree of agreement is given a numerical value from 1-
5. This is used predominately to measure attitudes and perceptions and is 
commonly used for surveys such as those in this study. For the purpose of 
this study, a 5-point scale will be used. For example, to the question "how 
likely would you consider having a tracheotomy placed if your breathing 
became labored?" answer options would be 5): very likely, 4): somewhat 
likely, 3): neutral, 2): somewhat unlikely or 1): very unlikely. In addition, 
patients will be asked to complete a mini-depression scale for evaluation for I 
potential depression, which could affect their end-of-life care decisions. 
; 
The physician surveys will contain the exact questions as in the patient 
surveys, except that the questions will be directed for the physicians to 
contemplate how they believe their ALS patients would answer these 
questions. For example, the above question would be written as "How likely 
do you think your ALS patient would consider having a tracheotomy placed 
if his/her breathing became labored?" Answer options would again be 5): 
very likely, 4): somewhat likely, 3): neutral, 2): somewhat unlikely or 1): -
very unlikely. Depression scales, however, will not be included in these 
surveys. 
?.n 
Questionnaires 
Patient Questionnaire-Sample Questions 
Category No. ofltems Sample Questions 
Patient characteristics 5-8 What is your marital 
status? 
Patient religious 1 Are you affiliated with 
affiliation any religious 
organization? 
Depression scale 5 Have you had feelings 
of worthlessness in the 
past 2 weeks? 
Pain/discomfort scale 5 Are you experiencing 
pain? How frequently? 
How severe? 
Advanced directives 2 Do you have any 
advance directive? 
Present treatment 5 Do you currently have 
or have had in the past a 
tracheotomy? A feeding 
tube? 
Future treatments 10 How likely would you 
consider having the 
following treatments if 
they were deemed 
necessary for life? 
PAS/euthanasia 5 If it were legal, how 
likely would you 
consider having help by 
a physician to end your 
life either now or in the 
future? 
Physician/patient 5 Has you primary 
Interaction physician discussed 
end-of-life care issues 
with you? 
Wrap-up 1-2 After having completed 
this survey, do you 
think any of your prior 
views/wishes may have 
changed? 
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Physician Questionnaire- Sample Questions 
Category No. ofltems Sample Questions 
Physician 5 How long have you 
been 
characteristics practicing? 
Physician religious 2 Are you affiliated with 
affiliation any religious 
organization? 
Patient types 5-10 What are the majority 
of diseases that you 
treat? 
ALS patients 5-10 HowmanyALS 
patients do you treat? 
What are their major 
disabilities, if any? 
ALS patients and 5-10 Are any of your ALS 
depression patients clinically 
depressed? Are any 
being treated for 
depression? 
ALS patients and pain 5 How much pain or 
discomfort do you think 
the majority of your 
ALS patients are in? 
Advanced directives 1-2 What proportion of 
your ALS patients has 
advanced directives? 
Present treatments 5 What proportion of 
your ALS patients has 
or have had 
tracheotomies? 
Future treatments 5-10 How likely do you 
think your ALS patients 
would consider having 
the following 
treatments if they were 
deemed necessary for 
life? 
?R 
Physician/patient 5-10 Do you discuss end-of-
interaction life issues or advanced 
directives with any of 
your patients? If so, 
how often? 
Physician's views on 5 How likely do you 
PAS/euthanasia think that 
PAS/euthanasia might 
be appropriate in 
certain cases? 
Physician's views on 5 If legalized, how likely 
practicing do you think you would 
PAS/euthanasia offer these services for 
your patients? 
Physician's 5-10 How likely do you 
understandings of ALS think your.ALS patients 
patients' wishes would consider PAS? 
regarding Euthanasia? 
PAS/euthanasia 
Wrap-up 1-2 Mter having completed 
this survey, do you 
think any of your prior 
views may have 
changed? 
Statistical Analysis 
Descriptive statistics will be tabulated for the study participants. Chi-square 
tests will be used to determine the significance of differences between 
patients and physician responses for all categorical variables. Differences in 
continuous variables will be calculated using the Mann-Whitney U Test. All 
tests will be two-sided and a p value of .05 or less will be considered 
statistically significant. 
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RESULTS 
Table- Patient Characteristics 
Age Range (mean) 
Female number(%) 
Male number(%) 
Race -Caucasian no. (%) 
African-American no.(%) 
Hispanic no.(%) 
Other no.(%) 
Number of years since ALS diagnosed 
range (mean) 
Are you married? 
Yes(%) 
No(%) 
Do you have any children? 
Yes(%) 
No(%) 
Do you have any religious affiliation? 
Yes(%) 
No(%) 
If yes, which type? 
-Protestant 
-Catholic 
-Judaism 
-Islam 
-other 
Education level 
<HS no. (mean) 
=HS no. (mean) 
>HS no. (mean) 
Advanced medical directives? 
Yes? no. (mean) 
No? no. (mean) 
Pain Score range (mean) 
Depression score range (mean) 
Insurance? 
Yes no.(%) 
No no.(%) 
10 
Overall Quality of life score range 
(mean) 
Table- Physician Characteristics 
Af!.e range (mean) 
Sex 
-Female no.(%) 
-Male no.(%) 
Race 
Caucasian no. (%) 
African-American no.(%) 
Hispanic no(%) 
Asian no.(%) 
Other no.(%) 
Religious affiliation? 
Yes no.(%) 
No no.(%) 
Practice type 
University-affiliated no. (%) 
Private clinic no. (%) 
Practice setting 
Rural no.(%) 
Urban no.(%) 
p . p f anent re erences C bl . k) d Ph . . ' A m uem an lYSICtans 
Type of Treatment Very Somewhat 
likely no. likely no. 
(%) (%) 
Ventilation 
Nutrition/hydration 
Resuscitation 
Pain medication 
Would consider 
suicide 
Would consider 
suicide with 
physician help 
Would consider 
euthanasia by 
physician 
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Not at all Unsure no. 
likely no. (%) 
(%) 
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DISCUSSION 
Based on previous studies, it is likely that the results of this study would 
indicate a significant gap between the wishes of ALS patients concerning 
end-of-life care and the assumptions made by their physicians. It is also likely 
that ALS patients would be more interested in pursuing PAS and/or 
euthanasia as options than their physicians would predict. There are many 
possible explanations for this. First, as revealed in the literature search 
earlier, physicians assumptions about their patients' desires might be 
influenced more by their own wishes rather than what their patients would 
want. Second, physicians, on average, spend too little time discussing such 
issues for many reasons including already-busy schedules, their own 
discomfort in broaching such topics with their patients and the belief that 
their patients would be offended or upset by these discussions. 15 Third, 
physicians may perceive offering PAS and euthanasia as failures on their part 
to combat their patients' disease or symptoms.17 Fourth, fear of discussing 
these polemic topics under current legal constraints may impede 
understanding of their patients' wishes.'" 
If physicians are underestimating their patients' interest in PAS and/or 
euthanasia, then ALS patients might be denied a desired service as long as 
PAS and euthanasia remain illegal. As previously stated, ALS patients have 
the potential to suffer immensely physically and emotionally. If a large 
portion of this population does indeed wish for the options for PAS and 
1?. 
euthanasia as a means to control the circumstances of their deaths, then the 
medical community needs to further explore all the issues concerning such 
practices. 
If the main hypothesis of this study is supported, then these results would be 
consistent with those of similar studies reviewed regarding several factors. 
For example, it is likely that the majority of patients who express interest in 
PAS or euthanasia will be Caucasian, educated, males with little or no 
religious affiliation. As previous studies revealed, interest in PAS or 
euthanasia does not imply that these acts will actually be committed. Reasons 
for this include unexpected death and improvement in treatments for 
depression and/or pain. Also, it is possible that patients who received lethal 
' prescriptions found comfort in knowing that assisted death was an option 
even if never used. It is important to note, however, that this study will not 
simply reiterate the results of previous studies, but will go a step further by 
assessing how much physicians understand their patients. 
Of course, questions regarding the ethical and practical issues of legalizing 
PAS/euthanasia will remain after this study. The concerns of abuse potential 
would need to be further addressed. However, we may find that rather than 
leading to abuse of patients, legalized PAS and euthanasia causes patients to 
receive better palliative care with improved treatment of pain and depression 
than is currently occurring. This may be due to increased awareness among 
physicians of palliative treatments if they must comply with procedures 
mandating that all these alternatives be exhausted before PAS and/or 
euthanasia can be enacted? 
Limitations to this study will include a small and selective sample size. Both 
physician and patient subjects would be selected only from North Carolina 
and thus are not necessarily representative of both general populations. There 
may also be a selection bias. Both subject populations may be comprised of 
those who already have an interest in the subjects of PAS/euthanasia and end-
of-life care. They may be more partial to legalizing PAS and euthanasia than 
the general populations. On the other hand, even with prior interest in these 
' 
• topics, both physicians and patients interviewed may tend to underreport any 
interest in legalization .. There are many possible reasons for this. Physicians 
may fear being "labeled" and may have concerns that, despite the anonymity 
of the study, their responses may be revealed to colleagues. Patients may be 
reluctant to express true feelings for fear of upsetting family members, 
especially if family members are present during interviews. Both physicians 
and patients may be reluctant to openly consider treatments that are currently 
illegal in most of the US. 
One of the major strengths of this study is that information is directly 
obtained from the ALS patients themselves, rather than via surrogates. This 
leads to less recall bias. In addition, this study will directly compare patients' 
wishes and physicians' assumptions. While some of this has been done, as 
reviewed earlier, none of these studies involved ALS patients specifically. 
The results of this pilot study can be used to guide further and much needed 
research in this area. 
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